Patents by Inventor Lixia Han

Lixia Han has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified compound of andrographolide
    Patent number: 10717720
    Abstract: The present disclosure discloses a modified compound of andrographolide, and particularly discloses a compound shown in formula (I) and (II) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 22, 2016
    Date of Patent: July 21, 2020
    Assignees: Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd., Medshine Discovery Inc.
    Inventors: Haiying He, Zhigan Jiang, Jianhua Xia, Jing Wang, Lixia Han, Lihong Lan, Hui Zhou, Kunmin Lai, Shuhui Chen
  • MODIFIED COMPOUND OF ANDROGRAPHOLIDE
    Publication number: 20180346438
    Abstract: The present disclosure discloses a modified compound of andrographolide, and particularly discloses a compound shown in formula (I) and (II) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 22, 2016
    Publication date: December 6, 2018
    Inventors: Haiying HE, Zhigan JIANG, Jianhua XIA, Jing WANG, Lixia HAN, Lihong LAN, Hui ZHOU, Kunmin LAI, Shuhui CHEN
  • Imidazole derivative used as antiviral agent and use thereof in preparation of medicament
    Patent number: 10030029
    Abstract: Disclosed are an antiviral compound and a use thereof in the preparation of a medicament for the treatment of virus infections. Specifically, the present invention relates an imidazole derivative for treating respiratory syncytial virus infection.
    Type: Grant
    Filed: September 19, 2017
    Date of Patent: July 24, 2018
    Assignee: Shandong Danhong Pharmaceutical Co., Ltd.
    Inventors: Haiying He, Weihua Shi, Zhigan Jiang, Lixia Han, Jikui Sun, Jian Li, Shuhui Chen
  • IMIDAZOLE DERIVATIVE USED AS ANTIVIRAL AGENT AND USE THEREOF IN PREPARATION OF MEDICAMENT
    Publication number: 20180009820
    Abstract: Disclosed are an antiviral compound and a use thereof in the preparation of a medicament for the treatment of virus infections. Specifically, the present invention relates an imidazole derivative for treating respiratory syncytial virus infection.
    Type: Application
    Filed: September 19, 2017
    Publication date: January 11, 2018
    Applicant: Shandong Danhong Pharmaceutical Co., Ltd.
    Inventors: Haiying He, Weihua Shi, Zhigan Jiang, Lixia Han, Jikui Sun, Jian Li, Shuhui Chen
  • Imidazole derivative used as antiviral agent and use therof in preparation of medicament
    Patent number: 9850251
    Abstract: Disclosed are an antiviral compound and a use thereof in the preparation of a medicament for the treatment of virus infections. Specifically, the present invention relates an imidazole derivative for treating respiratory syncytial virus infection.
    Type: Grant
    Filed: November 11, 2014
    Date of Patent: December 26, 2017
    Assignee: SHANDONG DANHONG PHARMACEUTICAL CO., LTD.
    Inventors: Haiying He, Weihua Shi, Zhigan Jiang, Lixia Han, Jikui Sun, Jian Li, Shuhui Chen
  • IMIDAZOLE DERIVATIVE USED AS ANTIVIRAL AGENT AND USE THEROF IN PREPARATION OF MEDICAMENT
    Publication number: 20160318943
    Abstract: Disclosed are an antiviral compound and a use thereof in the preparation of a medicament for the treatment of virus infections. Specifically, the present invention relates an imidazole derivative for treating respiratory syncytial virus infection.
    Type: Application
    Filed: November 11, 2014
    Publication date: November 3, 2016
    Inventors: Haiying He, Weihua Shi, Zhigan Jiang, Lixia Han, Jikui Sun, Jian Li, Shuhui Chen